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Abstract
Background: To report the prevalence of ear lobe crease (ELC), a sign of coronary heart disease,
in subjects (more than 40 years old) with diabetes and find its association with diabetic retinopathy.
Methods: Subjects were recruited from the Sankara Nethralaya Diabetic Retinopathy
Epidemiology And Molecular-genetics Study (SN-DREAMS), a cross-sectional study between 2003
and 2006; the data were analyzed for the1414 eligible subjects with diabetes. All patients' fundi
were photographed using 45° four-field stereoscopic digital photography. The diagnosis of diabetic
retinopathy was based on the modified Klein classification. The presence of ELC was evaluated on
physical examination.
Results: The prevalence of ELC, among the subjects with diabetes, was 59.7%. The ELC group
were older, had longer duration of diabetes, had poor glycemic control and had a high socio-
economic status compared to the group without ELC and the variables were statistically significant.
There was no statistical difference in the prevalence of diabetic retinopathy in two groups. On
multivariate analysis for any diabetic retinopathy, the adjusted OR for women was 0.69 (95% CI
0.51-0.93) (p = 0.014); for age >70 years, 0.49 (95% CI 0.26-0.89) (p = 0.024); for increasing
duration of diabetes (per year increase), 1.11(95% CI 1.09-1.14) (p < 0.0001); and for poor glycemic
control (per unit increase in glycosylated heamoglobin), 1.26 (95% CI 1.19-1.35) (p < 0.0001). For
sight-threatening diabetic retinopathy, no variable was significant on multivariable analysis. In
predicting any diabetic retinopathy, the presence of ELC had sensitivity of 60.4%, and specificity,
40.5%. The area under the ROC curve was 0.50 (95% CI 0.46-0.54) (p 0.02).
Conclusion: The ELC was observed in nearly 60% of the urban south Indian population. However,
the present study does not support the use of ELC as a screening tool for both any diabetic
retinopathy and sight-threatening retinopathy.
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Coronary heart disease (CHD) is a leading cause of mor-
tality in persons with type 2 diabetes [1]. In the general
population, macrovascular disease is the primary patho-
genic mechanism causing CHD; however, in population
with diabetes, it is the microvascular disease, in addition
to the macrovascular component, that may play a role in
the development of CHD. Recent evidences from the
ARIC (Atherosclerosis Risk In Communities) study sug-
gest that the presence of diabetic retinopathy (microvas-
cular disease) poses a two-fold higher risk of CHD
(macrovascular disease) and a three-fold higher risk of
fatal CHD; therefore, there is a link between macrovascu-
lar and microvascular pathogenic mechanisms [2].
The presence of ear lobe crease (ELC) and its association
with CHD was first described in 1973 [3]. Blodgett et al
found that 75% of CHD cases had ear lobe crease as com-
pared to 35% of the controls (age and gender matched)
[4]. Hence, there is a link between ELC and macrovascular
disease (CHD), and between, microvascular disease and
macrovascular disease. But what link we have between
ELC and microvascular disease, we do not know. The
present study is aimed to find out the prevalence of ELC
in south Indian diabetic population and its association
with diabetic retinopathy in a population-based study.
Methods
The study design and research methodology of SN-
DREAMS 1 are described in detail elsewhere [5]. The sam-
ple was stratified based on the socio-economic scoring:
low (score, 0-14), middle (score, 15-28), and high (score,
29-42) [6].
The scoring was calculated on the basis of several param-
eters such as ownership/type of residence (rent or own),
number of rooms in the house, educational status, salary,
occupation, material possessions (cycle, TV, audio, car
etc.) and house/land value. Eligible patients, above 40
years, were enumerated using the multistage random sam-
pling method. For all those who were not previously diag-
nosed to have diabetes diabetic, fasting blood glucose
estimation was done twice: first, in the field using capil-
lary blood, and second, at the base hospital using labora-
tory method (glucose oxidase method) [7]. Patients were
considered to be newly diagnosed with diabetes, if the
fasting blood glucose level was ≥110 mg/dl on two occa-
sions, as described above [8]. The study was approved by
the Institutional Review Board, and an informed consent
was obtained from all individuals.
Demographic data, socio-economic status, physical activ-
ity, risk of sleep apnea, dietary habits, and anthropometric
measurements were collected. A detailed medical and
ocular history and a comprehensive eye examination,
including stereo fundus photographs, were taken at the
base hospital. Biochemical investigations (Blood sugar,
total serum cholesterol, high-density lipoproteins, serum
triglycerides, hemoglobin, glycosylated hemoglobin
HbA1c) were conducted at the base hospital in fasting
state.
The presence of a diagonal ear lobe crease was assigned to
a person with a crease stretching obliquely from the outer
ear canal towards the border of the ear lobe of both the
ears; examiners were guided to diagnose the ELC, by com-
paring the features with the standard photograph pro-
vided to them.
Diabetic retinopathy was clinically graded using Klein's
classification (Modified Early Treatment Diabetic Retin-
opathy Study scales) [9]. The alternative method involves
grading all stereoscopic standard fields as a whole, and
assigning a level of severity for the eye according to the
greatest degree of retinopathy using a modified Airlie
House Classification scheme. Retinal photographs were
taken after pupillary dilatation (Carl Zeiss Fundus Cam-
era, Visucamlite, Jena, Germany); all patients underwent
45° four-field stereoscopic digital photography (posterior
pole, nasal, field, superior, and inferior). All photographs
were graded by two independent observers in a masked
fashion; the grading agreement was high (k = 0.83) [5].
Sight-threatening diabetic retinopathy was defined as the
presence of severe non-proliferative diabetic retinopathy,
proliferative diabetic retinopathy and clinically significant
macular edema [10].
Of the 5,999 subjects enumerated, 5,778 (96.32%)
responded for the first fasting blood sugar estimation. Of
the 5,778 subjects, 1,816 individuals (1,349 with known
history of diabetes and 467 with provisionally diagnosed
diabetes) were invited to visit the base hospital. Of the
1,563 (85.60%) who responded, 138 were excluded; in
two, the age criteria was not met, and in 136, the second
fasting blood sugar was ≤ 110 mg/dl). Provisionally diag-
nosed diabetes was defined as new asymptomatic individ-
ual with a first fasting blood glucose level ≥ 110 mg/dl. An
additional 11 individuals were excluded as their digital
fundus photographs were of poor quality, making them
ungradable for further analysis. Thus, a total of 1,414 indi-
viduals were analyzed for the study.
Results
Of the 1,414 subjects who were analyzed for diabetic
retinopathy, the mean age was 56.3 ± 10 yrs; 750
(53.04%) were men, and 664 were (46.96%), women.
The prevalence of ELC in the diabetic population was 844
(59.7%) (95% CI 57.1 - 62.2)); ELC was evident in both
the ears, in all subjects. Diabetic retinopathy was seen in
255 (18.03%) (95%CI 16.06-20.13) subjects.Page 2 of 5
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the ELC group and the group without ELC. The subjects in
ELC group (844) were older, had longer duration of dia-
betes, had poor glycemic control, and had a high socio-
economic status as compared to the group without ELC
(570); all variables were statistically significant. No differ-
ences were observed between the two groups with regard
to gender, smoking and alcohol, diabetic retinopathy,
BMI, Blood pressure, serum lipids and microalbuminuria.
Table 2 shows the results of logistic regression analysis,
keeping diabetic retinopathy as an outcome variable. For
any diabetic retinopathy, the univariate analyses identi-
fied several associated factors: women OR 0.64 (95% CI
0.49-0.85) (p = 0.002), for 50-59 years, OR was 1.7 (95%
CI 1.18-2.44) (p = 0.012), for 60-69 years, OR was 1.7
(95% CI 1.13-2.45) (p = 0.010), increasing duration of
diabetes per year OR 1.1 (95% CI 1.09-1.13) (p < 0.0001),
and poor glycemic control (per unit increase in glyco-
sylated heamoglobin) OR 1.3 (95% CI 1.21-1.36) (p <
0.0001). In multivariate analysis, the adjustments were
done for age, gender, duration of diabetes, serum lipids,
blood pressure, socio-economic status and glycemic con-
trol. From the multivariate analysis, the adjusted OR for
women was 0.69 (95% CI 0.51-0.93) (p = 0.014); for age
>70 years, 0.49 (95% CI 0.26-0.89) (p = 0.024); for
increasing duration of diabetes (per year increase),
1.11(95% CI 1.09-1.14) (p < 0.0001); for presence of
ELC, 0.88 (95% CI 0.65-1.19) (p = 0.422) and for poor
glycemic control (per unit increase in glycosylated heamo-
globin), 1.26 (95% CI 1.19-1.35) (p < 0.0001).
For sight-threatening diabetic retinopathy, the univariate
analysis revealed the following risk factors: presence of ear
lobe crease OR was 2.02 (95% CI 1.02-4.73) (p = 0.04)
and the OR for the increasing duration of diabetes (per
year) was 1.05 (95% CI 1.00-1.10) (p = 0.045). No varia-
ble was significant on the multivariable analysis. The
adjusted OR for ELC was 2.00 (95% CI 0.91-4.35) (p =
0.086).
Compared to the gold standard — photographic classifi-
cation — in diagnosing sight-threatening diabetic retin-
opathy, the presence of ELC had a sensitivity of 75%, and
specificity of 42.3%. The positive predictive value was
only 19.8%. The area under the ROC curve was 0.59 (95%
Table 1: Clinical and Laboratory characteristics in ELC group versus non-ELC group
ELC Group (Present) n = 844 ELC Group (absent)
n = 570
P value
Age (years) 57.39+/-10.13 54.75+/-9.65 <0.0001
Gender
Male 463 (54.9) 287 (50.4) 0.1076
Female 381 (45.1) 283 (49.6) 0.1076
Smoking 169 (20.0) 108 (18.9) 0.6576
Alcohol 175 (20.73) 135 (23.68) 0.2114
Retinopathy group
No DR 690 (81.8) 469 (82.3) 0.8654
Any DR 154 (18.2) 101 (17.71) 0.8657
NST 124 (14.7) 91 (16.0) 0.5538
ST 30 (3.6) 10 (1.8) 0.0680
Duration of DM (months) 79.90+/-76.66 70.86+/-73.91 0.0275
BMI (Kg/m2) 25.48+/-4.16 25.22+/-3.98 0.2410
BP Systolic (mmHg) 139.51+/-21.13 138.57+/-20.27 0.4044
BP Diastolic (mmHg) 81.98+/-11.33 81.93+/-11.44 0.9354
Glycosylated Hb 8.34+/-2.25 7.99+/-2.11 0.0033
Serum cholesterol (mg/dL) 186.77+/-39.77 186.16+/-42.19 0.7826
Serum HDL (mg/dL) 39.35+/-9.66 39.06+/-10.91 0.5994
Ratio HDL/cholestrol 0.200+/-0.059 0.204+/-0.064 0.2272
SES
Lower 653 (77.36) 500 (87.71) <0.0001
Upper 191 (22.6) 70 (12.3) <0.0001
Microalbuminuria
Normal 681 (80.7) 469 (82.3) 0.4914
Microalbuminuria 139 (16.5) 87 (15.3) 0.6670
Clinical microbuminuria 24 (2.8) 14 (2.5) 0.8612
ELC: Ear lobe crease, DR: Diabetic retinopathy, NST: Non-Sight threatening diabetic retinopathy including mild and moderate non-proliferative 
diabetic retinopathy, ST: Sight threatening diabetic retinopathy including severe non-proliferative diabetic retinopathy, proliferative diabetic 
retinopathy and diabetic macular edema, DM: Diabetes mellitus, BMI: Body mass index, BP: Blood pressure, Hb: Heamoglobin, HDL: High density 
lipoprotein, SES: Socioeconomic status.Page 3 of 5
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opathy, the presence of ELC had sensitivity of 60.4%, and
specificity, 40.5%. The area under the ROC curve was 0.50
(95% CI 0.46-0.54) (p 0.02).
Discussion
The diagonal ELC has been suggested as a simple marker
of vascular disease in the general population, but in pop-
ulation with diabetes (population with increased risk of
microangiopathy) only limited data are available [11].
The Fremantle diabetes study reported the prevalence of
ELC to be 55% in the western Australian population [11].
Our data suggest that the ELC was present in 59.7% of the
diabetic population > 40 years in the urban south Indian
population.
The present study shows that the subjects in the ELC
group were older, had longer duration of diabetes and had
poor glycemic control. Similar observations were found in
the Fremantle study [11]. Subjects with ELC had a higher
socio-economic status as compared to the group without
ELC; this could be an indirect measure of the population
that is at a greater risk for coronary artery disease.
With regards to the association between ELC and any dia-
betic retinopathy, we noted that increasing age, poor gly-
cemic control and increasing duration of diabetes were
significant variables in both univariate and multivariate
models. Similar observations were made in other popula-
tion-based studies on diabetic retinopathy [12-15].
Regarding the association between ELC and sight-threat-
ening diabetic retinopathy, the univariate analysis
showed that subjects with ELC had almost twice the risk
of developing sight-threatening diabetic retinopathy. The
possible explanations for this association include loss of
elastin; this might be responsible for ear lobe crease and
similar loss of elastin in a retinal blood vessel might
account for increased leakage and dilatation. The other
speculation is the ischemia; the focal ischemia of the der-
mal fat might cause ear lobe crease, and ischemia in retina
causes sight- threatening changes. However, these specu-
lations need further studies. Further, in multivariate anal-
ysis, when the effect of other variables was adjusted, the
association between the ELC and the sight-threatening
diabetic retinopathy was not significant. Taking into con-
sideration the low sensitivity and specificity value along
with low positive predictive value, the presence of ELC
Table 2: Regression Analysis to study the effect of various risk factors on Diabetic Retinopathy and Sight-threatening Diabetic 
Retinopathy.
Diabetic Retinopathy Sight-threatening Diabetic Retinopathy
Univariate Analysis Multivariate analysis Univariate Analysis Multivariate analysis
OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p
Gender
Men 1 1 1 1
Women 0.64 0.49-0.85 0.002 0.69 0.51-0.93 0.014 0.86 0.42-1.73 0.667 0.92 0.44-1.91 0.822
SES
Lower 1 1 1 1
Upper 0.09 0.63-1.29 0.584 0.72 0.48-1.07 0.104 1.24 0.53-2.92 0.617 1.00 0.39-2.52 0.996
Ear lobe crease
Absent 1 1 1 1
Present 1.036 0.79-1.37 0.800 0.88 0.65-1.19 0.422 2.02 1.02-4.73 0.043 2.00 0.91-4.34 0.086
Age groups (years)
40-49 1 1 1 1
50-59 1.698 1.18-2.44 0.012 1.38 0.94-2.04 0.100 2.39 0.76-7.15 0.135 2.13 0.66-6.80 0.204
60-69 1.665 1.13-2.45 0.010 1.08 0.71-1.66 0.710 2.86 0.88-9.24 0.079 2.43 0.73-8.08 0.148
≥ 70 1.120 0.66-1.88 0.673 0.49 0.26-0.89 0.024 3.22 0.78-13.30 0.106 2.83 0.65-12.32 0.167
Duration of Diabetes 
(per year increase)
1.110 1.09-1.13 <0.0001 1.11 1.09-1.14 <0.0001 1.050 1.00-1.10 0.046 1.04 0.99-1.09 0.123
HbA1c (per unit increase) 1.280 1.21-1.36 <0.0001 1.26 1.19-1.35 <0.0001 1.060 0.93-1.22 0.383 1.07 0.93-1.25 0.343
OR: Odds Ratio, SES: Socioeconomic status, CI: Confidence interval, HbA1c: Glycosylated heamoglobinPage 4 of 5
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cannot be used as a screening tool to predict diabetic
retinopathy, including sight-threatening diabetic retinop-
athy.
The strength of this study was that it used photography
and standard grading techniques for diabetic retinopathy.
Further, the study was representative of a large population
and results could be extrapolated to the whole of urban
India. One of the limitations of the study was not studying
the non-diabetic population with regards to ELC; it would
have been interesting to compare the findings with sub-
jects without diabetes. The second limitation was not
grading ear lobe crease; recent evidence has pointed out to
the relationship between the increasing grades of ELC and
the increasing severity of coronary artery disease[16].
Thirdly, the sample in the subgroup of sight-threatening
diabetic retinopathy is small; -thus, a lower power in this
subgroup analysis.
Conclusion
ELC is present in nearly 60% of urban south Indian pop-
ulation with diabetes, aged above 40 years. The presence
of ELC is somewhat related to sight-threatening diabetic
retinopathy on univariate analysis.
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